Physician profile
David J Porter
NPI 1467410100
$4,290.17
in general payments reported to CMS, 2019-2025
41 companies · $925 in 2025
The $925 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $762 · 2020: $471 · 2021: $77.94 · 2022: $506 · 2023: $887 · 2024: $661 · 2025: $925.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,472.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $831.12 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $404.79 | 2019-2025 | |
| Lilly USA, LLC | $364.73 | 2019-2025 | Zepbound, Jardiance, Mounjaro |
| Stryker Corporation | $330.20 | 2024-2025 | Inbone, Prophecy, Invision |
| Glaxosmithkline, LLC. | $321.61 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $230.05 | 2019-2025 | |
| Astellas Pharma US INC | $178.84 | 2020-2025 | Veozah |
| Novartis Pharmaceuticals Corporation | $161.03 | 2022-2025 | |
| Amgen INC. | $154.10 | 2019-2025 | Evenity |
| Astrazeneca Pharmaceuticals LP | $117.91 | 2020-2025 | |
| Sanofi Pasteur INC. | $114.15 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $81.03 | 2019-2024 | |
| Otsuka America Pharmaceutical, INC. | $70.72 | 2020-2023 | Rexulti |
| Edwards Lifesciences Corporation | $69.23 | 2022 | |
| Exact Sciences Corporation | $63.22 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.